Boehringer Ingleheim Takes Biggest Price Increases In 2005, AARP Report Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Increases for respiratory inhalers Atrovent and Combivent contributed to 17% average price growth in 2005 for BI’s major products, according to AARP “Rx Watchdog Report.”
You may also be interested in...
Ambien Price Jumps Highest In Q1 Among Drugs Monitored By AARP
Manufacturer prices for 193 brand name prescription drugs rose an average of 3.9% in the first quarter, AARP says.
Ambien Price Jumps Highest In Q1 Among Drugs Monitored By AARP
Manufacturer prices for 193 brand name prescription drugs rose an average of 3.9% in the first quarter, AARP says.
Brand Name Drug Prices Increased 7.1% In 2004, AARP Report Says
The latest "Rx Watchdog Report" says wholesale acquisition cost for 195 brand name drugs increased at double the rate of general inflation. Prices for 75 generic drugs rose 0.5%, less than one-fifth the inflation rate. A PhRMA study found consumer medical costs increased 4.7%, compared to 4% for branded and generic drugs.